Stock comparison
Eli Lilly
Perrigo
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
PRGO
Perrigo
Market cap
$1.55B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | PRGO | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 32F | LLY |
| Benjamin Graham | 86A | 32F | LLY |
| Philip Fisher | 86A | 20F | LLY |
| Peter Lynch | 74B | 16F | LLY |
| Joel Greenblatt | 78C | 19F | LLY |
| Charlie Munger | 85A | 23F | LLY |
| Terry Smith | 77C | 14F | LLY |
Side-by-side metrics
| Metric | LLY | PRGO |
|---|---|---|
| Market cap | $1T | $1.55B |
| P/E (TTM) | 36.6x | - |
| EV/EBIT | 34.1x | 14.5x |
| ROIC (TTM) | 32.06% | 3.37% |
| Gross margin | 83.51% | 34.17% |
| Net margin | 34.98% | -43.5% |
| Revenue CAGR 5y | 23.17% | 0.68% |
| EPS CAGR 5y | 40.81% | - |
| Debt / Equity | 1.4x | 1.5x |
| Dividend yield | 0.62% | 10.43% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Net margin34.98%vs -43.5%+180%
- Market cap$1Tvs $1.55B+100%
- Revenue CAGR 5y23.17%vs 0.68%+97%
- ROIC (TTM)32.06%vs 3.37%+89%
PRGO leads on
- P/E (TTM)-vs 36.6x+102%
- Dividend yield10.43%vs 0.62%+94%
- EV/EBIT14.5xvs 34.1x+57%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.